Mark V. Mishra, MD

Mark V. Mishra, MD

Neurologic Radiation Oncology, Breast Radiation Oncology, Genitourinary Radiation Oncology, Radiation Oncology

Associate Professor of Radiation Oncology , Director of Clinical Research , Associate Director for UM Cancer Networks

Mark V. Mishra, MD

UM Faculty Physicians, Inc.

Available for Telehealth Visits

Languages: English

Gender: Male

Locations

Radiation Oncology UMH

22 South Greene Street
Baltimore, MD 21201
Get Directions

PH: 410-328-6080

FAX: 410-328-6993

Radiation Oncology - MPTC

850 West Baltimore Street
Baltimore, MD 21201
Get Directions

PH: 410-369-5200

FAX: 410-347-0891

About Me

Dr. Mishra focuses on treating patients for tumors of the central nervous system and genitourinary tract as well as breast cancer.

Dr. Mishra is an associate professor of radiation oncology at the University of Maryland School of Medicine. He also serves as director of Clinical Research for the Department of Radiation Oncology. In addition, he is vice chair of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center's (UMGCCC) Clinical Research Committee and associate director of UM Cancer Networks. He is also chair of the Radiation Oncology Executive Academic and Advisory Council.

As director of Radiation Oncology Clinical Research, Dr. Mishra oversees all clinical trial activities for Radiation Oncology at UMGCCC and at affiliated practices across the state of Maryland. He also serves as the UMGCCC voting-member contact PI for NRG Oncology.

Dr. Mishra’s research focus is centered on evaluating the comparative and cost effectiveness of new and complex radiation technologies such as proton beam therapy as well as evaluating novel uses of radiation therapy alone or in combination with other therapies. He has received the American Society of Radiation Oncology (ASTRO) Comparative Effectiveness Grant and is the Comparative Effectiveness co-chair for two recently activated national phase III studies (NRG BN009 and NRG CC009) focused on identifying new treatment approaches for brain metastases. He is also the PI for two investigator-initiated trials at UMGCCC evaluating the efficacy of combining laser interstitial thermal therapy with radiation for patients with a recurrent glioma as well as patients with a newly diagnosed unresectable glioma.

Dr. Mishra is a graduate of the University of Cincinnati College of Medicine (Cincinnati, Ohio) and completed his residency in radiation oncology at Thomas Jefferson University (Philadelphia, Pennsylvania), where he served as chief resident. He completed a clinical research fellowship in the National Institutes of Health (NIH) Clinical Research Training Program and also completed the Program in Clinical Effectiveness at the Harvard T.H. Chan School of Public Health (Boston, Massachusetts).

As a result of his clinical trial work at UMGCCC, Dr. Mishra is a recipient of the National Cancer Institute Cancer Center Investigator Team Leadership Award. His research has been supported by the NIH, the Patient-Centered Outcomes Research Institute (PCORI), the American Society for Radiation Oncology (ASTRO) and the Keep Punching Foundation. He has served as a member of the PCORI Patient Engagement Advisory Panel and on national level committees for ASTRO, the American College of Radiology, and the American Board of Radiology. His research has resulted in more than 75 peer-reviewed publications with more than 1,100 citations to date.

Dr. Mishra has been recognized as a "Top Doctor" by Baltimore Magazine.